Add office photos
Employer?
Claim Account for FREE
DIVI'S Laboratories
3.8
based on 1.3k Reviews
Company Overview
Company Locations
Working at DIVI'S Laboratories
Company Summary
DIVI'S Laboratories is a major player in the global API market, focusing on high-quality active pharmaceutical ingredients for various international markets.
Overall Rating
3.8/5
based on 1.3k reviews
On-Par
with industry average
Highly rated for
Job security
Critically rated for
Work satisfaction, Promotions, Company culture
Work Policy
Work from office
91% employees reported
Rotational Shift
45% employees reported
Strict timing
59% employees reported
No travel
57% employees reported
View detailed work policy
Top Employees Benefits
Free meal
95 employees reported
Job/Soft skill training
87 employees reported
Health insurance
63 employees reported
Office gym
28 employees reported
View all benefits
About DIVI'S Laboratories
Founded in1990 (35 yrs old)
India Employee Count5k-10k
Global Employee Count10k-50k
India HeadquartersHyderabad/Secunderabad, Telangana, India
Office Locations
--
Websitedivislabs.com
Primary Industry
Other Industries
--
Are you managing DIVI'S Laboratories's employer brand? To edit company information,
claim this page for free
Divi’s Laboratories Limited is one of the largest API companies in the world, with ~$730M in revenue and exporting to more than 95 countries.
Mission: To be a good corporate citizen and not only add value in our core competency areas of Pharma but also serve the community at large through social, educational and environmental initiatives that would establish strong foundations for a better tomorrow.
Vision: To maintain leadership in custom synthesis of APIs and Intermediates for health care and life sciences industry and to be one of the top companies world-wide in the domain. To develop generic APIs for the late life cycle needs of the Industry.
Managing your company's employer brand?
Claim this Company Page for FREE
DIVI'S Laboratories Ratings
based on 1.3k reviews
Overall Rating
3.8/5
How AmbitionBox ratings work?
5
487
4
416
3
235
2
67
1
132
Category Ratings
4.0
Job security
3.6
Salary
3.5
Work-life balance
3.5
Skill development
3.3
Company culture
3.3
Promotions
3.3
Work satisfaction
DIVI'S Laboratories is rated 3.8 out of 5 stars on AmbitionBox, based on 1.3k company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at DIVI'S Laboratories
based on 1.2k reviews
4.0
Rated by 148 Women
Rated 4.3 for Job security and 3.8 for Skill development
3.8
Rated by 1.1k Men
Rated 4.0 for Job security and 3.6 for Salary
Work Policy at DIVI'S Laboratories
based on 84 reviews in last 6 months
Work from office
91%
Permanent work from home
6%
Hybrid
3%
DIVI'S Laboratories Reviews
Top mentions in DIVI'S Laboratories Reviews
+ 5 more
Compare DIVI'S Laboratories with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.8/5 based on 1.3k reviews | 4.0/5 based on 5.6k reviews | 4.1/5 based on 6.7k reviews | 5.0/5 based on 1 reviews |
Highly Rated for | Job security | Salary Job security Skill development | Skill development Salary Work-life balance | Skill development Work-life balance Salary |
Critically Rated for | Company culture Promotions Work satisfaction | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 91% employees reported | Work from office 83% employees reported | Work from office 72% employees reported | - |
Rating by Women Employees | 4.0 Good rated by 148 women | 4.0 Good rated by 417 women | 4.1 Good rated by 650 women | - no rating available |
Rating by Men Employees | 3.8 Good rated by 1.1k men | 4.0 Good rated by 4.9k men | 4.1 Good rated by 5.6k men | - no rating available |
Job security | 4.0 Good | 3.9 Good | 3.7 Good | 4.0 Good |
View more
DIVI'S Laboratories Salaries
DIVI'S Laboratories salaries have received with an average score of 3.6 out of 5 by 1.3k employees.
Chemist
(759 salaries)
Unlock
₹1.2 L/yr - ₹5.6 L/yr
Production Chemist
(548 salaries)
Unlock
₹1.2 L/yr - ₹5 L/yr
Supervisor
(474 salaries)
Unlock
₹1.1 L/yr - ₹5.7 L/yr
Production Supervisor
(346 salaries)
Unlock
₹1.7 L/yr - ₹5.5 L/yr
Analyst
(332 salaries)
Unlock
₹1.7 L/yr - ₹7 L/yr
Maintenance Engineer
(163 salaries)
Unlock
₹1.5 L/yr - ₹7.2 L/yr
Quality Analyst
(141 salaries)
Unlock
₹1.8 L/yr - ₹4.7 L/yr
Maintenance Supervisor
(131 salaries)
Unlock
₹1.9 L/yr - ₹5.4 L/yr
QC Analyst
(129 salaries)
Unlock
₹1.9 L/yr - ₹5.5 L/yr
Quality Control Analyst
(83 salaries)
Unlock
₹1.9 L/yr - ₹4 L/yr
DIVI'S Laboratories Interview Questions
Interview questions by designation
Top DIVI'S Laboratories interview questions and answers
Get interview-ready with top interview questions
DIVI'S Laboratories News
View all
Divi's Labs Starts Commercial Operations At Kakinada Greenfield Project
- Divi's Laboratories has started commercial operations at its Kakinada plant in Andhra Pradesh.
- The first phase of the project is being implemented on 200 acres of the 500-acre Unit III site, with an estimated investment between Rs 1,200 crores to Rs 1,500 crore.
- Divi's Labs currently operates two manufacturing sites near Hyderabad and Visakhapatnam, making it one of the largest active pharmaceutical ingredients manufacturing facilities in the world.
- The company reported a strong performance in the second quarter, with a 22.5% increase in consolidated revenue and a significant rise in net profit.
Bloomberg Quint | 2 Jan, 2025
F&O Strategy: Divi’s Lab; Bull call spread
- Immediate support levels for the stock are at ₹5,750 and ₹5,423.
- If the stock manages to close above ₹5,950, it has the potential to reach a new high.
- Divi’s Lab witnessed a healthy rollover of 31% to January series.
- Consider a bull-call spread strategy using January options with a net cost of ₹4,315.
HinduBusinessLine | 21 Dec, 2024
Divi's Lab Clarifies After US Court Paves Way For Novartis' Heart Drug Generic; Share Price Down
- Divi's Laboratories' shares fell over 3% as a US court dismissed Novartis AG's bid to block the launch of a generic version of its heart drug Entresto.
- Divi's Labs has a contract manufacturing organisation pact with Novartis for Entresto.
- The launch of the generic drug by MSN Pharmaceuticals is expected to impact the market share of Entresto.
- Divi's Labs clarified that it sees no material impact from this news.
Bloomberg Quint | 5 Dec, 2024
Five Stocks To Buy: How To Trade Balrampur Chini, Divi's Lab, Skipper, Orient Cement, Crompton
- Analysts have shared 'buy' calls on shares of Balrampur Chini Mills, Divis Laboratories, Skipper, Orient Cement, and Crompton Greaves Consumer Electricals.
- Balrampur Chini Mills: The stock should be bought at Rs 585 with a target price of Rs 610 and stop loss of Rs 585.
- Divis Laboratories: Buy shares at a target price of Rs 6,550 and a stop loss of Rs 6,050.
- Skipper: Buy shares at Rs 578 with a target price range of Rs 618 to 630 and a stop loss at Rs 560.
- Orient Cement: Buy shares at Rs 342 with a target price of Rs 364 and a stop loss of Rs 332.
- Crompton: Buy shares at Rs 409 with a target price range of Rs 432 and a stop loss at Rs 398.
Bloomberg Quint | 2 Dec, 2024
Broker’s call: Divi’s Lab (Sell)
- Divi’s Laboratories reported better-than-expected Q2FY24 revenue, but lower EBITDA margin.
- Revenue was 8% ahead of estimates and EBITDA 6% ahead.
- Management suggests revenue growth came from custom synthesis, while generics face pricing pressures.
- The stock is overhyped due to the BioSecure Act; sell rating with a target price of ₹3,890.
HinduBusinessLine | 11 Nov, 2024
Divi's Labs Q2 Results Review - Custom Synthesis Drives Earnings: Dolat Capital
- Divi's Labs Q2 Results Review - Custom Synthesis Drives Earnings: Dolat Capital
- With the recent rally in the stock price, there is a limited upside and thus the brokerage maintains ‘Reduce’ rating with a target price of Rs 6,149 at 50 times FY27 P/E.
Bloomberg Quint | 11 Nov, 2024
Divi's Labs Q2 Review: Should You Buy The Stock After Earnings? Here's What Brokerages Say
- Divi's Labs reported a 47% uptick in net profit for the September quarter.
- Jefferies maintains 'hold' rating, citing concerns over high valuations and pricing pressures in generics segment.
- Nuvama and Citi upgrade targets, highlighting potential in custom synthesis, peptides, and GLP-1 portfolio.
- Shares of Divi's Labs closed slightly lower, with a year-to-date rise of 52.41%.
Bloomberg Quint | 11 Nov, 2024
Divi's Laboratories Q2 Results: Profit Jumps 47%, Beats Estimates
- Divi's Laboratories reported a 47% surge in net profit, beating estimates.
- The company's net profit rose to Rs 510 crore compared to Rs 348 crore last year.
- Revenue for the quarter stood at Rs 2,338 crore, up 22.5% from the previous year.
- Margins expanded to 31% from 25% for the year-ago period.
Bloomberg Quint | 9 Nov, 2024
Asian Paints, Aurobindo Pharma, Divi's Labs Q2 Results Today — Earnings Estimates
- Asian Paints is anticipated to post a profit of Rs 1,079 crore, while Aurobindo Pharma is likely to report a profit of Rs 972 crore.
- Divi's Laboratories is expected to announce a net profit of Rs 479 crore with revenue estimated at Rs 2,215 crore.
- Other notable companies announcing earnings on Saturday include Advanced Enzyme Technologies Ltd, Data Patterns (India) Ltd, Epigral Ltd, and HBL Power Systems Ltd.
- Key focus for analysts is the growth in revenue and profitability for the quarter ended Sept 30.
Bloomberg Quint | 9 Nov, 2024
Powered by
DIVI'S Laboratories Offices
Compare DIVI'S Laboratories with
Biocon Limited
3.9
Zydus Lifesciences
4.1
Glenmark Pharmaceuticals
3.9
Torrent Pharmaceuticals
3.9
Lupin
4.2
Aurobindo Pharma
4.0
Piramal Group
3.8
Dr. Reddy's
4.1
Alembic Pharmaceuticals
4.0
Ipca Laboratories
4.0
Abbott
4.1
Alkem Laboratories
3.9
Ajanta Pharma
4.0
Cadila Pharmaceuticals
3.5
Laurus Labs
4.2
AstraZeneca
4.1
Akums Drugs & Pharmaceuticals Limited
4.4
Pfizer
4.0
Granules India
3.9
Indoco Remedies
3.6
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to DIVI'S Laboratories
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.6k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Cipla
Manufacturing, Pharma
4.1
• 6.7k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.8k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 5.9k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.8k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.4k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 5.9k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.6k reviews
Piramal Group
Pharma
3.8
• 1.1k reviews
Dr. Reddy's
Clinical Research, Pharma
4.1
• 6.6k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3k reviews
DIVI'S Laboratories FAQs
When was DIVI'S Laboratories founded?
DIVI'S Laboratories was founded in 1990. The company has been operating for 35 years primarily in the Pharma sector.
Where is the DIVI'S Laboratories headquarters located?
DIVI'S Laboratories is headquartered in Hyderabad/Secunderabad, Telangana.
How many employees does DIVI'S Laboratories have in India?
DIVI'S Laboratories currently has more than 9,700+ employees in India. Production, Manufacturing & Engineering department appears to have the highest employee count in DIVI'S Laboratories based on the number of reviews submitted on AmbitionBox.
Does DIVI'S Laboratories have good work-life balance?
DIVI'S Laboratories has a Work-Life Balance Rating of 3.5 out of 5 based on 1,300+ employee reviews on AmbitionBox. 68% employees rated DIVI'S Laboratories 4 or above, while 32% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read DIVI'S Laboratories work-life balance reviews for more details
Is DIVI'S Laboratories good for career growth?
Career growth at DIVI'S Laboratories is rated as moderate, with a promotions and appraisal rating of 3.3. 32% employees rated DIVI'S Laboratories 3 or below, while 68% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading DIVI'S Laboratories promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in DIVI'S Laboratories?
Working at DIVI'S Laboratories comes with several advantages and disadvantages. It is highly rated for job security. However, it is poorly rated for work satisfaction, promotions / appraisal and company culture, based on 1,300+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
